Cojutti, Pier Giorgio <br/><br/>
Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with haematological malignancies.  [electronic resource] 

 -  British journal of clinical pharmacology  11 2018 
 - 2544-2550 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1365-2125 
<br/><br/><label>Standard No.: </label>10.1111/bcp.13707  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antifungal Agents--administration & dosage<br/>Delayed-Action Preparations<br/>Drug Interactions<br/>Drug Monitoring--methods<br/>Female<br/>Glucocorticoids--administration & dosage<br/>Graft vs Host Disease--therapy<br/>Hematologic Neoplasms--therapy<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Humans<br/>Invasive Fungal Infections--prevention & control<br/>Male<br/>Middle Aged<br/>Proton Pump Inhibitors--administration & dosage<br/>Retrospective Studies<br/>Risk Factors<br/>Tablets<br/>Triazoles--administration & dosage